Hainan Haide Capital Management Co Ltd
SZSE:000567
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
4.52
9.48
|
| Price Target |
|
We'll email you a reminder when the closing price reaches CNY.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Hainan Haide Capital Management Co Ltd
Other Current Liabilities
Hainan Haide Capital Management Co Ltd
Other Current Liabilities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Other Current Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
H
|
Hainan Haide Capital Management Co Ltd
SZSE:000567
|
Other Current Liabilities
¥171.6m
|
CAGR 3-Years
27%
|
CAGR 5-Years
44%
|
CAGR 10-Years
18%
|
|
|
China Huarong Asset Management Co Ltd
HKEX:2799
|
Other Current Liabilities
¥24B
|
CAGR 3-Years
-60%
|
CAGR 5-Years
-42%
|
CAGR 10-Years
N/A
|
|
|
A
|
Anxin Trust Co Ltd
SSE:600816
|
Other Current Liabilities
¥7.5B
|
CAGR 3-Years
-25%
|
CAGR 5-Years
-14%
|
CAGR 10-Years
37%
|
|
|
Kunwu Jiuding Investment Holdings Co Ltd
SSE:600053
|
Other Current Liabilities
¥103.2m
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-43%
|
CAGR 10-Years
-24%
|
|
|
Shaanxi International Trust Co Ltd
SZSE:000563
|
Other Current Liabilities
¥5.3B
|
CAGR 3-Years
185%
|
CAGR 5-Years
133%
|
CAGR 10-Years
44%
|
|
|
Yangzijiang Financial Holding Ltd
SGX:YF8
|
Other Current Liabilities
S$89.3m
|
CAGR 3-Years
-9%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Hainan Haide Capital Management Co Ltd
Glance View
Hainan Haide Capital Management Co Ltd. has emerged as a formidable player in the ever-evolving landscape of China's financial sector. Founded with an ambition to capture the intricate opportunities within the burgeoning Chinese economy, the company has strategically positioned itself at the intersection of traditional investment approaches and innovative financial solutions. As China's regulatory environment continues to balance liberalization with rigorous oversight, Haide Capital deftly navigates these waters by focusing on assets within the realms of hedge funds, private equity, and venture capital. The firm meticulously crafts its portfolio to leverage growth sectors across industries like technology, healthcare, and sustainable energy, ensuring its investment thesis aligns with the broader macroeconomic trends shaping the future of the Chinese market. This financial powerhouse generates its revenue primarily through a dual structure of management fees and performance-based compensation. By instituting a fee model that combines a percentage of assets under management with a share of profits on successful investments, Haide Capital aligns its interests closely with those of its clients, ensuring a focus on sustainable, long-term gains. The company utilizes a robust, research-driven approach to asset management, employing a team of seasoned analysts and market experts who dissect economic data, sector dynamics, and competitive benchmarks. This enables Haide Capital to not only mitigate risks but also amplify returns for their diverse clientele, establishing a sterling reputation and trust in the highly competitive world of capital management.
See Also
What is Hainan Haide Capital Management Co Ltd's Other Current Liabilities?
Other Current Liabilities
171.6m
CNY
Based on the financial report for Sep 30, 2024, Hainan Haide Capital Management Co Ltd's Other Current Liabilities amounts to 171.6m CNY.
What is Hainan Haide Capital Management Co Ltd's Other Current Liabilities growth rate?
Other Current Liabilities CAGR 10Y
18%
Over the last year, the Other Current Liabilities growth was 28%. The average annual Other Current Liabilities growth rates for Hainan Haide Capital Management Co Ltd have been 27% over the past three years , 44% over the past five years , and 18% over the past ten years .
You don't have any saved screeners yet
